Bromobenzene 3,4-oxide (1), the putative toxic metabolite of bromoben- zene, is known to alkylate protein sulfur nucleophiles in vivo and is postulated to alkylate protein nitrogen nucleophiles, the expected products of which would include, after hydrolysis, N τ -(p-bromophenyl)- L-histidine (8) and N e -(p-bromophenyl)-L-lysine (7). These non-protei- nogenic amino acids have now been synthesized by unambiguous routes and their stability under protein hydrolysis conditions demonstrated. Trea- tment of N α -Cb 2 -lysine with sodium nitroprusside gave the e-lysinol derivative, which by successive treatment with CBr 4 /Ph 3 P and excess p-bromoaniline and deprotection (6.0 M HCl, 110 o C) afforded an overall 14% yield of (7). Alkylation of N α -Ac-L-histidine methyl ester with p-fluoronitrobenzene, followed by reduction, a modified Sandmeyer bromo- dediazotization (tert-BuONO/CuBr 2 ), and deprotection afforded (8) in 10% overall yield. An unexpected N τ - to N π -aryl migration was observed during hydrogenation of a N τ -(p-nitrophenyl)histidine derivative over Pd/charcoal; it was avoided by use of SnCl 2 /ethanol for nitro reduc- tion. The N α -acetyl derivatives of (7) and (8), of interest as haptens for use in raising antibodies against proteins alkylated by epoxide (1), were also prepared and characterized